These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23567763)

  • 1. [The MADIT-RIT study].
    Proclemer A; Locati ET
    G Ital Cardiol (Rome); 2013 Apr; 14(4):241-5. PubMed ID: 23567763
    [No Abstract]   [Full Text] [Related]  

  • 2. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.
    Reynolds MR; Josephson ME
    Circulation; 2003 Oct; 108(15):1779-83. PubMed ID: 14557341
    [No Abstract]   [Full Text] [Related]  

  • 3. Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
    Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):27-30. PubMed ID: 9080863
    [No Abstract]   [Full Text] [Related]  

  • 4. Which device should "MADIT protocol" patients receive? Multicenter Automatic Defibrillator Implantation Trial.
    Higgins SL; Klein H; Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):31-5. PubMed ID: 9080864
    [No Abstract]   [Full Text] [Related]  

  • 5. MADIT-II and implications for noninvasive electrophysiologic testing.
    Moss AJ
    Ann Noninvasive Electrocardiol; 2002 Jul; 7(3):179-80. PubMed ID: 12167176
    [No Abstract]   [Full Text] [Related]  

  • 6. Wider use for implantable defibrillators.
    Harv Heart Lett; 2002 Jun; 12(10):4-5. PubMed ID: 12079822
    [No Abstract]   [Full Text] [Related]  

  • 7. The implantable cardioverter defibrillator.
    Coltorti F; Senatore C; Marrazzo N; Franciosa P; Nocerino P; Solimene F; D'Isa S; Galizia GL; Chiariello M
    Rev Port Cardiol; 1998 Nov; 17 Suppl 3():III23-6. PubMed ID: 9857742
    [No Abstract]   [Full Text] [Related]  

  • 8. Avoiding unnecessary aggressive ICD programming after MADIT-RIT and ADVANCE III trials.
    Gasparini M
    J Am Coll Cardiol; 2014 Jan; 63(2):189-90. PubMed ID: 24140667
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply: Avoiding unnecessary aggressive ICD programming after MADIT-RIT and ADVANCE III trials.
    Powell BD
    J Am Coll Cardiol; 2014 Jan; 63(2):190. PubMed ID: 24140670
    [No Abstract]   [Full Text] [Related]  

  • 10. Special report: cost-effectiveness of implantable cardioverter-defibrillators in a MADIT-II population.
    Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(3):1-2. PubMed ID: 15314827
    [No Abstract]   [Full Text] [Related]  

  • 11. The AVID trial--another embarrassment.
    Nomof N
    Am J Cardiol; 1998 Feb; 81(4):530. PubMed ID: 9485153
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical research designs and implantable defibrillator indications: spend in the beginning or pay at the end.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 2006 Jan; 47(1):108-11. PubMed ID: 16386672
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is prophylaxis the best use of the ICD?
    Nisam S; Farré J
    Eur Heart J; 2002 May; 23(9):700-5. PubMed ID: 11977995
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.
    Mower MM
    Md Med J; 1997 Feb; 46(2):75-8. PubMed ID: 9029905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].
    Disertori M
    G Ital Cardiol (Rome); 2011 May; 12(5):374-8; discussion 378. PubMed ID: 21593957
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular arrhythmias in heart failure.
    Batsford WP; Mickleborough LL; Elefteriades JA
    Cardiol Clin; 1995 Feb; 13(1):87-91. PubMed ID: 7796435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.